#immunovant
Latest news and interesting information about immunovant.
Immunovant stock jumps 20% on RA trial
Immunovant stock jumps 20% after positive rheumatoid arthritis trial data for IMVT-1402.
...
→
EN ▾
Dmitri Mariyasin: Earthquakes Reveal Urban Structural WeaknessesTSX futures rise on inflation worries, Nvidia earningsTrump and Netanyahu had dramatic call on IranWarning to drivers: Visibility will be limitedPDD Holdings SWOT: Temu growth vs regulatory risksEarthquake cities can become resilience modelsChip stocks rally ahead of Nvidia resultsMcKinsey partner joins Verisk boardLZ Technology executes 1-for-20 reverse stock splitNaaS Technology terminates warrants for $4.5MDmitri Mariyasin: Earthquakes Reveal Urban Structural WeaknessesTSX futures rise on inflation worries, Nvidia earningsTrump and Netanyahu had dramatic call on IranWarning to drivers: Visibility will be limitedPDD Holdings SWOT: Temu growth vs regulatory risksEarthquake cities can become resilience modelsChip stocks rally ahead of Nvidia resultsMcKinsey partner joins Verisk boardLZ Technology executes 1-for-20 reverse stock splitNaaS Technology terminates warrants for $4.5M